Fimaporfin

N/A

Report date: 2024/03/20 11:41:51

Base Information

Drug NameFimaporfin
Drug Alias NameAmphinexPC-A11PC-A22TPCS-2ATPCS2a
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhotosensitizers
TargetsNot applicable
Therapy Area/IndicationsSkin NeoplasmsHead and Neck NeoplasmsSquamous Cell Carcinoma of Head and Neck +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesUkraine +[17] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPci Biotech As
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPci Biotech As
Active IndicationsN/A
Inactive IndicationsSkin NeoplasmsHead and Neck NeoplasmsSquamous Cell Carcinoma of Head and Neck +[4] 

Other Information

ATC CodeN/A
Related LinksN/A